Multiyear partnership brings together advanced technology, industry expertise and scale to help researchers interpret an unprecedented amount of biomedical data and derive insights to advance the treatment of human diseases
CAMBRIDGE, Mass., SOUTH SAN FRANCISCO, Calif., and REDMOND, Wash. — Jan. 11, 2021 — On Monday, Broad Institute of MIT and Harvard, Verily, an Alphabet company, and Microsoft Corp. announced a strategic partnership to accelerate new innovations in biomedicine through the Terra platform. Terra, originally developed by Verily and the Broad Institute, is a secure, scalable, open-source platform for biomedical researchers to access data, run analysis tools and collaborate. Terra is actively used by thousands of researchers every month to analyze data from millions of participants in important scientific research projects.
Biomedical data are being generated and digitized at a historic rate and are expected to reach dozens of exabytes by 2025 — including data from genomics, medical imaging, biometric signals and electronic health records. Coupled with powerful research and analysis tools, these datasets can provide lifesaving insights into some of the world’s most pressing health issues. But making use of these important datasets remains difficult for researchers who face huge, siloed data estates, disparate tools, fragmented systems and data standards, and varying governance and security policies.
The new partnership aims to break through those barriers by bringing together Microsoft’s cloud, data and AI technologies, and global network of more